While not everyone who takes a GLP-1 will develop this condition, its essential to know the signs
The momentum for oral GLP-1 therapies presents a significant opportunity for market expansion
Review these questions with your healthcare provider: Do you have other medical conditions, including problems with your pancreas or kidneys, or severe problems with your liver, severe problems with your stomach, such as slowed emptying of your stomach (gastroparesis) or problems digesting food
Every program is supervised by licensed medical professionals for your safety and success
[] Furthermore, an investigation is required with more extensive clinical evidence to use therapeutically incretin-based medication including tirzepatide in neurological disease
This has also fueled the rise of unregulated, influencer-promoted peptides sold online, placing patients at risk